Kimberly Gentile - Nov 2, 2023 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role
SVP, Clinical Operations
Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Nov 2, 2023
Transactions value $
$0
Form type
4
Date filed
11/6/2023, 08:32 PM
Previous filing
Oct 5, 2022
Next filing
Jan 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Options (Right to buy) Award $0 +78.8K $0.00 78.8K Nov 2, 2023 Common Shares 78.8K $29.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in four equal installments on November 2, 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service with the Issuer at each vesting date.